Takeshi Horai

Takeshi Horai

UNVERIFIED PROFILE

Are you Takeshi Horai?   Register this Author

Register author
Takeshi Horai

Takeshi Horai

Publications by authors named "Takeshi Horai"

Are you Takeshi Horai?   Register this Author

42Publications

660Reads

32Profile Views

Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC.

Int J Clin Oncol 2020 Jan 10;25(1):67-73. Epub 2019 Sep 10.

Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake 3-8-31, Koto, Tokyo, 1358550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-019-01537-4DOI Listing
January 2020

Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer.

Lung Cancer 2016 Mar 30;93:43-6. Epub 2015 Dec 30.

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ward, Tokyo 135-8550, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.12.011DOI Listing
March 2016

Phase II study of docetaxel-plus-bevacizumab combination therapy in patients previously treated for advanced non-squamous non-small cell lung cancer.

Anticancer Res 2014 Sep;34(9):5153-8

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

View Article

Download full-text PDF

Source
September 2014

A subset of small cell lung cancer with low neuroendocrine expression and good prognosis: a comparison study of surgical and inoperable cases with biopsy.

Hum Pathol 2014 May 23;45(5):1045-56. Epub 2014 Jan 23.

Division of Pathology, The Cancer Institute, The Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), Tokyo 135-8550, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.01.001DOI Listing
May 2014

Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancer.

Anticancer Res 2014 Apr;34(4):1975-81

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
April 2014

LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both.

J Clin Oncol 2013 Sep 1;31(27):3335-41. Epub 2013 Jul 1.

Nobuyuki Katakami, Kobe City Medical Center General Hospital, Kobe; Shinji Atagi, National Hospital Organization Kinki-Chuo Chest Medical Center; Koji Takeda, Osaka City General Hospital; Kazuto Nishio, Kinki University, Osaka; Koichi Goto, National Cancer Center Hospital East, Chiba; Toyoaki Hida, Aichi Cancer Center Hospital, Nagoya; Takeshi Horai, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo; Akira Inoue, Tohoku University Hospital, Sendai; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Kunihiko Koboyashi, Saitama International Medical Center, Saitama; Katsuyuki Kiura, Okayama University, Okayama; Yoko Seki and Ryuichi Ebisawa, Nippon Boehringer Ingelheim; Nobuyuki Yamamoto, Shizuoka Cancer Center, Shizuoka, Japan; and Mehdi Shahidi, Boehringer Ingelheim, Bracknell, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.0981DOI Listing
September 2013

A phase II study of S-1 in relapsed small cell lung cancer.

Mol Clin Oncol 2013 Mar 14;1(2):263-266. Epub 2013 Jan 14.

Thoracic Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2013.67DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915806PMC
March 2013

Randomized phase II study of two schedules of carboplatin and gemcitabine for stage IIIB and IV advanced non-small cell lung cancer (JACCRO LC-01 study).

Chemotherapy 2011 6;57(4):357-62. Epub 2011 Sep 6.

Department of Thoracic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan. imamura-fu @ mc.pref.osaka.jp

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/330481
Publisher Site
http://dx.doi.org/10.1159/000330481DOI Listing
February 2012

[A case of adenocarcinoma of the lung with a pulmonary thromboembolism which improved with gefitinib].

Nihon Kokyuki Gakkai Zasshi 2011 Apr;49(4):282-6

Japanese Foundation for Cancer Research, Thoracic Oncology Center.

View Article

Download full-text PDF

Source
April 2011

[A case of endobronchial granular cell tumor].

Nihon Kokyuki Gakkai Zasshi 2011 Feb;49(2):128-30

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research.

View Article

Download full-text PDF

Source
February 2011

Discriminant model for cytologic distinction of large cell neuroendocrine carcinoma from small cell carcinoma of the lung.

J Thorac Oncol 2010 Apr;5(4):472-8

Department of Cytology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181ce3cddDOI Listing
April 2010

Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.

Anticancer Res 2010 Feb;30(2):557-63

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan.

View Article

Download full-text PDF

Source
February 2010

Association of cytologic micropapillary clusters in cytology samples with lymphatic spread in clinical stage I lung adenocarcinomas.

Lung Cancer 2009 Jun 21;64(3):277-81. Epub 2008 Nov 21.

Department of Cytology, The Cancer Institute Hospital, The Japanese Foundation for Cancer Research, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.09.017DOI Listing
June 2009

Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer.

Cancer Chemother Pharmacol 2008 Mar 5;61(3):503-8. Epub 2007 May 5.

Thoracic Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-007-0496-6DOI Listing
March 2008

Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology.

Ann Thorac Surg 2007 Jan;83(1):197-202

Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2006.08.025DOI Listing
January 2007

Gefitinib efficacy associated with multiple expression of HER family in non-small cell lung cancer.

Anticancer Res 2006 Sep-Oct;26(5B):3761-5

Thoracic Oncology Center, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
December 2006

Postoperative ischemic change in bronchial stumps after primary lung cancer resection.

Eur J Cardiothorac Surg 2006 Jul 26;30(1):172-6. Epub 2006 May 26.

Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejcts.2006.03.047DOI Listing
July 2006

Cytology of pulmonary adenocarcinomas showing enteric differentiation.

Acta Cytol 2006 May-Jun;50(3):250-6

Department of Cytology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku. Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000325950DOI Listing
July 2006

Antipyrine test predicts pharmacodynamics in docetaxel and cisplatin combination chemotherapy.

Lung Cancer 2005 Aug;49(2):245-51

Division of Internal Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Kami-ikebukuro 1-37-1, Toshima-ku, Tokyo 170-8455, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2005.02.007DOI Listing
August 2005

Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer.

Lung Cancer 2005 Apr;48(1):115-9

Division of Internal Medicine, Cancer Institute Hospital, Japanese Foundation For Cancer Research, Kami-ikebukuro 1-37-1, Toshima-ku, Tokyo 170-8455, Japan.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950020400478
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2004.09.006DOI Listing
April 2005

Micropapillary clusters in early-stage lung adenocarcinomas: a distinct cytologic sign of significantly poor prognosis.

Cancer 2004 Apr;102(2):81-6

Department of Cytology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20125DOI Listing
April 2004

[Diagnostic cytology for lung cancer].

Nihon Rinsho 2002 May;60 Suppl 5:151-5

Department of Chest Surgery, Cancer Institute Hospital.

View Article

Download full-text PDF

Source
May 2002